Recent filings for Abeona Therapeutics Inc. (NASDAQ: ABEO) reveal notable insider activity. On November 13, 2025, Director Alvino Mark sold 15,000 shares for a total of $71,168, priced at $4.74 per share. After the transaction, Alvino now holds 62,252 shares, valued at roughly $0.3 million. Interestingly, Alvino subsequently bought back 15,000 shares, generating the same total value of $71,168, reflecting active stake management.
Prior to these transactions, CEO Seshadri Vishwas sold 249 shares for $1,366, executed at $5.49 per share. Following this sale, Vishwas retains 1,189,818 shares, worth approximately $5.81 million, demonstrating continued significant personal investment in the company.
Analyst Coverage and Ratings
Abeona Therapeutics has attracted attention from several analysts. Oppenheimer initiated coverage in early March 2025 with an Outperform rating, signaling confidence in the company’s potential. H.C. Wainwright began coverage on July 3, 2024, issuing a Buy recommendation, while Stifel started coverage on May 30, 2024, also rating ABEO as a Buy. These analyst endorsements reflect an overall positive outlook for the company, particularly within the biotechnology sector.
Price Performance Overview
On Tuesday, ABEO stock surged 6.32%, closing at $4.88. Over the past five trading days, shares have gained 8.93%, indicating short-term bullish momentum. Despite this recent rally, the stock has declined 15.72% year-to-date and 12.39% over the past year, reflecting ongoing volatility in the biotech sector.
The stock reached a 52-week high of $7.54 on August 15, 2025, and a 52-week low of $3.93 on April 9, 2025, illustrating a wide trading range and highlighting opportunities for investors monitoring fluctuations.
Support and Resistance Levels
Technical analysis identifies key levels for ABEO. The stock currently has support at $4.68, with a secondary support level at $4.49, suggesting areas where buying interest may emerge. On the upside, resistance is found at $4.99, with an additional resistance level at $5.10, indicating potential short-term targets for upward movement.
Short Interest Trends
Short interest in ABEO has risen sharply. As of November 14, 2025, short positions increased by 4.4 million shares, totaling 13.59 million shares. For comparison, short interest on October 15, 2025, was 9.19 million shares, representing a 32.39% increase.
This growth in short interest, while significant, can also indicate positive sentiment, as investors may anticipate a rebound or view the stock as undervalued.
